FSHD-specific functional rating scale clinical trials

Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD

This study aims to improve how we test new treatments for Facioscapulohumeral Muscular Dystrophy (FSHD). Researchers are developing new ways to measure the disease and planning how to choose the right people for future drug trials, helping get effective medicines to patients sooner.